Hjem › Melanom › Pennsylvania › Pittsburgh
Melanom kliniske forsøg i Pittsburgh, PA
31 studier for Melanom søger deltagere på steder i og omkring Pittsburgh (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RekruttererFase 3
- University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
RekruttererFase 3
- Allegheny Health Network, Pittsburgh
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
RekruttererFase 2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
RekruttererFase 3
- UPMC Hillman Cancer Center, Pittsburgh
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RekruttererFase 2
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
RekruttererFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
RekruttererFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruttererFase 1/2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Project: Every Child for Younger Patients With Cancer
RekruttererObservationsstudie
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Research Site, Pittsburgh
Investigating Real-Time Immunotherapy Symptoms Study
Rekrutterer
- UPMC Hillman Cancer Center, Pittsburgh
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
RekruttererFase 1/2
- Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RekruttererFase 2
- UPMC Hillman Cancer Center, Pittsburgh
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
RekruttererFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
RekruttererObservationsstudie
- UPMC Hillman Cancer Center, Pittsburgh
Evaluation of Hypoxia in Primary Melanoma
RekruttererObservationsstudie
- UPMC Hillman Cancer Center, Pittsburgh
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
RekruttererFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
RekruttererFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Neoadjuvant Darovasertib in Primary Uveal Melanoma
RekruttererFase 3
- UPMC Hillman Cancer Center, Pittsburgh
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
RekruttererFase 1/2
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
RekruttererFase 1
- UPMC Hillman Cancer Center, Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
RekruttererFase 2
- UPMC Hillman Cancer Center, Pittsburgh
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
RekruttererTidlig fase 1
- UPMC Hillman Cancer Center, Pittsburgh
A Study of VET3-TGI in Patients With Solid Tumors
RekruttererFase 1
- UPMC- Hillman Cancer Center, Pittsburgh
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RekruttererFase 2/3
- UPMC Hillman Cancer Center, Pittsburgh
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
RekruttererFase 3
- UPMC Hillman Cancer Center, Pittsburgh
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
RekruttererObservationsstudie
- UPMC Hillman Cancer Center, Pittsburgh
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
RekruttererFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
RekruttererFase 1/2
- University of Pittsburgh, Pittsburgh
Melanom forsøg i andre byer
- Houston, TX59 studier
- New York City, NY38 studier
- Los Angeles, CA34 studier
- Nashville, TN33 studier
- Boston, MA26 studier
- Philadelphia, PA23 studier
- San Francisco, CA22 studier
- Durham, NC21 studier
- Atlanta, GA21 studier
- St. Louis, MO21 studier
- Salt Lake City, UT21 studier
- Columbus, OH21 studier
Andre studier i Pittsburgh
- Ikke-småcellet lungecancer48 studier
- Kræft (alle typer)41 studier
- Brystkræft39 studier
- Colorektal kræft32 studier
- Metastatisk cancer31 studier
- Ægstockræft30 studier
- Livmoderslimhindekræft23 studier
- Lungecancer23 studier
- Prostatakræft23 studier
- Slagtilfælde22 studier
- Pladecellekræft i hoved og hals22 studier
- Depression22 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.